Incidence and Treatment Patterns in Hospitalizations for Malignant Spinal Cord Compression in the United States, 1998–2006 Kimberley S. Mak, B.A., Leslie.

Slides:

Advertisements

Similar presentations

National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.

Advertisements

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review David.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.

The Case for Prostate Brachytherapy in the Affordable Care Act Era

Thyroid cancer burden in Central and South America

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Thyroid cancer burden in Central and South America

European Journal of Cancer

The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study Alan M. Nichol,

Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer

Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From.

A Dose Escalation and Pharmacodynamic Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer Ludmila Katherine Martin, MD,

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy

Dose-Volume Histogram Predictors of Chronic Gastrointestinal Complications After Radical Hysterectomy and Postoperative Concurrent Nedaplatin-Based Chemoradiation.

T. Liu, J. Zhou, S. A. Woodhouse, P. B. Schiff, P. Zhang, K. S

Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy Afshin Rashtian, M.D., Shawn Iganej,

Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, M.D., Bruce.

The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy C.

Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.

A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute Thomas J. FitzGerald,

Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long- Term Follow-up Bas Kreike, M.D., Augustinus A.M. Hart, M.Sc., Tony.

Marion Piñeros, Mónica S. Sierra, M. Isabel Izarzugaza, David Forman

Stomach cancer burden in Central and South America

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.

Lifetime Increased Cancer Risk in Mice Following Exposure to Clinical Proton Beam– Generated Neutrons Leo E. Gerweck, PhD, Peigen Huang, MD, Hsiao-Ming.

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials Gustavo Arruda Viani,

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases Isabelle Thibault, MD, Mikki Campbell,

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis Yi-Jhih.

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,

Epidemiology of Environmental Exposure and Malignant Mesothelioma

Susanna L. Matsen, MD, Bruce A. Perler, MD, MBA, David C

Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk John A. Sandoval,

Update on Spinal Cord Compression for the Palliative Care Clinician

Epidemiology of Environmental Exposure and Malignant Mesothelioma

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Fetal Pig Dissection Study Material.

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Incidence and Mortality Rates of Syncope in the United States

Epidemiology of Myelodysplastic Syndromes

The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis Annemarie T. Fernandes, BA, Eric.

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Palliative Care: An Evolving Field in Medicine

The Melanoma Epidemic Thus Far

Ting-Yuan David Cheng, PhD, Susanna M. Cramb, PhD, Peter D

Shih-Jen Hwang, Guillermina Lozano, Christopher I. Amos, Louise C

Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V

Relationship Between Tumor Size and Survival in Non–Small-Cell Lung Cancer (NSCLC): An Analysis of the Surveillance, Epidemiology, and End Results (SEER)

Aaron P. Thrift, PhD Clinical Gastroenterology and Hepatology

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Vincent L. Rowe, MD, William Lee, MD, Fred A

Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A

Susanna L. Matsen, MD, David C. Chang, PhD, MPH, MBA, Bruce A

“It Depends”: Viewpoints of Patients, Physicians, and Nurses on Patient-Practitioner Prayer in the Setting of Advanced Cancer Michael J. Balboni, PhD,

U.S. Hospice Benefits Journal of Pain and Symptom Management

Study Designs in Patient-Oriented Research

Shikhar Agarwal, MD, MPH The American Journal of Medicine

The failure of breast cancer screening

Epidemiologic Support for Melanoma Heterogeneity Using the Surveillance, Epidemiology, and End Results Program Anne M. Lachiewicz, Marianne Berwick,

Observations on emerging patterns of asthma in our society

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

Vivek Singam, BLA, Kevin R. Patel, BS, Harrison H

Lung Cancer in New Zealand: Patterns of Secondary Care and Implications for Survival Wendy Stevens, MBBS, Graham Stevens, MD, FRANZCR, John Kolbe, MBBS,

Fetal Pig Dissection Study Material.

Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk John A. Sandoval,

Epidemiology of Thymoma and Associated Malignancies

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Presentation transcript:

Incidence and Treatment Patterns in Hospitalizations for Malignant Spinal Cord Compression in the United States, 1998–2006 Kimberley S. Mak, B.A., Leslie K. Lee, B.Sc., Raymond H. Mak, M.D., Shuang Wang, Ph.D., John Pile-Spellman, M.D., Janet L. Abrahm, M.D., Holly G. Prigerson, Ph.D., Tracy A. Balboni, M.D., M.P.H. International Journal of Radiation Oncology • Biology • Physics Volume 80, Issue 3, Pages 824-831 (July 2011) DOI: 10.1016/j.ijrobp.2010.03.022 Copyright © 2011 Elsevier Inc. Terms and Conditions

Fig. 1 Proportion of cases, average annual incidence among patients dying of cancer, and inpatient mortality rate by underlying cancer diagnosis in malignant spinal cord compression (MSCC)-related hospitalizations, 1998–2006. CNS = central nervous system; GI = gastrointestinal; N/A = not available. *Estimates of average annual incidence of MSCC-related hospitalization among patients dying of cancer, plotted on a log scale. Error bars represent standard deviation. †Error bars represent standard errors among sample clusters. ‡Raw incidence; not age-adjusted. ‖Two or more International Classification of Diseases, 9th revision codes for primary cancers listed. ¶International Classification of Diseases, 9th revision codes for neoplasms with an undetermined histologic diagnosis, such as those with diagnosis still in process. §Surveillance, Epidemiology and End Results cancer death data not available for histologic subtype. **Malignant neoplasm of nasal cavities, middle ear, and accessory sinuses; pleura; thymus, heart, and mediastinum; other and ill-defined sites within the respiratory system and intrathoracic organs; male breast; placenta; other and unspecified female organs; testis; penis and other male genital organs; eye; endocrine glands and related structures; as well as Kaposi's sarcoma and neuroendocrine tumors. ††Include cancers originating in the gallbladder, small intestine, peritoneum, and retroperitoneum, but not the esophagus, stomach, liver, pancreas, colon, rectum, or anus. International Journal of Radiation Oncology • Biology • Physics 2011 80, 824-831DOI: (10.1016/j.ijrobp.2010.03.022) Copyright © 2011 Elsevier Inc. Terms and Conditions